GLP-1Ra was linked to a decrease in fracture risk (overall response 0.71, 95% CI 0.560.91) compared to placebo or other anti-diabetic medications [78]
Marketed under brand names such as Ozempic and Wegovy, semaglutide belongs to a class of drugs known as GLP-1 receptor agonists
While effective, Wegovy can interact with other drugs, supplements, and substances, which may alter its benefits or cause unwanted side effects
Were designed to help you lose fat, not strength so your results hold up when you taper off
All my labs are great, my blood pressure is normal, physically I dont really feel any different than I did before I lost weight. A 58(1.73 m) woman got rid of 50 pounds (23 kg), getting thinner from 218 pounds (99 kg) to 168 pounds (76 kg) in one year of using Ozempic [31]
Tirzepatide generally produces greater average weight loss in clinical trials, with the SURMOUNT-1 trial showing up to 22.5% body weight reduction at the highest dose compared to semaglutide roughly 15-17% in comparable trials
